Table 2.
Events | Model 1 | Model 2 | Model 3 | Model 4 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | ||
iHF | |||||||||||||
Non-NAFLD | 4902 | Ref. | Ref. | Ref. | Ref. | ||||||||
Regressed NAFLD | 326 | 1.507 | 1.348–1.686 | < 0.001 | 1.237 | 1.102–1.388 | < 0.001 | 1.219 | 1.087–1.368 | < 0.001 | 1.049 | 0.935–1.178 | 0.414 |
Incident NAFLD | 332 | 1.478 | 1.322–1.651 | < 0.001 | 1.326 | 1.181–1.489 | < 0.001 | 1.307 | 1.164–1.469 | < 0.001 | 1.150 | 1.024–1.292 | 0.018 |
Persistent NAFLD | 626 | 1.827 | 1.681–1.986 | < 0.001 | 1.619 | 1.471–1.782 | < 0.001 | 1.575 | 1.430–1.736 | < 0.001 | 1.316 | 1.194–1.450 | < 0.001 |
Persistent NAFLD | 626 | Ref. | Ref. | Ref. | Ref. | ||||||||
Regressed NAFLD | 326 | 0.825 | 0.722–0.943 | 0.005 | 0.753 | 0.652–0.870 | < 0.001 | 0.752 | 0.650–0.869 | < 0.001 | 0.800 | 0.691–0.925 | 0.003 |
hHF | |||||||||||||
Non-NAFLD | 2,067 | Ref. | Ref. | Ref. | Ref. | ||||||||
Regressed NAFLD | 129 | 1.408 | 1.179–1.682 | < 0.001 | 1.285 | 1.071–1.542 | 0.007 | 1.249 | 1.041–1.499 | 0.017 | 1.101 | 0.916–1.322 | 0.305 |
Incident NAFLD | 120 | 1.264 | 1.052–1.520 | 0.013 | 1.328 | 1.098–1.608 | 0.004 | 1.289 | 1.065–1.561 | 0.009 | 1.162 | 0.959–1.407 | 0.125 |
Persistent NAFLD | 263 | 1.822 | 1.603–2.072 | < 0.001 | 2.048 | 1.767–2.373 | < 0.001 | 1.939 | 1.671–2.251 | < 0.001 | 1.666 | 1.434–1.935 | < 0.001 |
Persistent NAFLD | 263 | Ref. | Ref. | Ref. | Ref. | ||||||||
Regressed NAFLD | 129 | 0.773 | 0.626–0.954 | 0.017 | 0.607 | 0.484–0.760 | < 0.001 | 0.616 | 0.491–0.773 | < 0.001 | 0.645 | 0.514–0.810 | < 0.001 |
CI confidence interval, HR hazard ratio, iHF incident heart failure, hHF hospitalized heart failure
Model 1: Crude
Model 2: Age, sex, and body weight
Model 3: Model 2 + alcohol consumption, smoking, regular exercise, and income status
Model 4: Model 3 + hypertension, diabetes mellitus, dyslipidemia, and estimated glomerular filtration rate